Comparison

公众号助手 vs EviMed

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

公众号助手

Features
Read full description

公众号助手是一款微信官方出品的应用。它能将你的iPhone变成一个随身的公众号“工作室”,无论身处何地,你都可以发表内容、与读者互动。简洁的编辑工具让每个人轻松变身为作者,留住即刻的灵感,尽享内容创作的乐趣。公众号助手让每个有才华的个体都有机会被关注,都有自己的品牌。 为什么要使用公众号助手: - 实时互动:第一时间收到来自读者的消息并及时回复,或使用星标功能精选优质留言,向大众公开。 - 便捷创作:在编辑图文消息时,可一键添加图片和音乐;也可以快速的发布图片和文字消息。没有及时发出的图文消息会被存储在草稿箱里。还可以随时修改已发文章中的错别字。 - 用户管理:使用关注者排行榜来了解最关心你的读者,或使用数据统计来随时了解最新的文章阅读、用户分享情况。 - 帐号管理:可在手机上修改公众号头像、名称和简介。

About

EviMed

This app acts as an AI-powered medical knowledge engine. It searches, analyzes, and synthesizes information from millions of global medical documents to provide evidence-based answers to clinical questions. It is intended for reference and should not replace professional medical advice.

Highlights
  • AI medical knowledge search
  • Evidence-based Q&A
  • Analysis of medical literature
  • Synthesis of key information
  • Real-time data updates
  • Clinical trial data integration
Features
Read full description

EviMed专注于医学知识搜索引擎、医学知识分析服务及AI医学循证问答机器人的构建,可基于任意给定的临床问题,在实时更新的全球数亿项中英文文献、指南/共识、药品说明书临床试验等数据中自动进行搜索、筛选,分析和挖掘,将关键信息进行抽取与知识合成,最终得到定性/定量的结论,并自动进行循证回答。 免责声明: EviMed平台内提供的报告或内容只作为建议参考,不能代替到医院就诊。用户在做出任何医疗决定之前,还应寻求医生的建议。

Screenshots

公众号助手4 screens
EviMed4 screens

Verdict

The call

The clearest difference is rating: EviMed at 5.0 against 公众号助手's 2.1. 公众号助手's advantage is in-app purchases (none vs 10) and ratings volume (54 vs 1). On price, update cadence, ads and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. EviMed sells 10 one-off in-app purchases. 公众号助手 asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

EviMed holds the better App Store score, 5.0 against 2.1. That said, the two scores are not equally well evidenced: 公众号助手 has 54 ratings behind it against 1, so its average is the more settled of the two.

UpkeepUpdate frequency

公众号助手 ships an update every 3 weeks, EviMed every 2 weeks. The most recent releases landed on November 19, 2026 and November 17, 2026 respectively.

Scorecard3 real differences · 7 level
公众号助手 versus EviMed: the parameters behind the verdict, then further details
Parameter公众号助手EviMed
PriceFreeFree
Rating2.1 (54 ratings)5.0 (1 ratings) — better
Positive reviews31.3% of reviews—
Number of ratings54 — better1
Update frequencyEvery 3 weeksEvery 2 weeks — better
AdsNoNo
In-app purchasesNo — betterYes
Monetization—Free with in-app purchases
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS15.015
Further details — not scored
Size255 MB68 MB
Age rating17+17+
DeveloperTencent Technology (Shenzhen) Company Limited灵犀量子(北京)医疗科技有限公司

Customer experience

公众号助手

All ratings54 ratings
Positive25.9%
Neutral0.0%
Negative74.1%
Written reviews115 reviews
Positive31.3%
Neutral17.4%
Negative51.3%

EviMed

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

公众号助手

No in-app purchases

10 purchases

EviMed

One-time10
  • 超级会员-基础版(月会员)$39.99
  • EviMed 药品遴选会员(月会员)$59.99
  • EviMed 药品遴选会员(季度)$129.99
Show 7 more
  • 超级会员-专业版(月会员)$149.99
  • EviMed 药学联合会员(季度)$199.99
  • EviMed 药品遴选会员(半年度)$299.99
  • EviMed 药学联合会员(半年度)$349.99
  • EviMed 药品遴选会员(年度)$399.99
  • 超级会员-基础版(年会员)$399.99
  • 超级会员-旗舰版(月会员)$399.99

Questions

Is 公众号助手 free?
公众号助手 is free to download, with no in-app purchases.
Is EviMed free?
EviMed is free to download, with in-app purchases available.
Which has better reviews, 公众号助手 or EviMed?
EviMed is rated higher. 公众号助手 averages 2.1 out of 5 from 54 ratings, while EviMed averages 5.0 from 1 ratings.
Do 公众号助手 or EviMed have ads?
Neither 公众号助手 nor EviMed shows ads.
Which is updated more often, 公众号助手 or EviMed?
公众号助手 ships an update every 3 weeks, and EviMed every 2 weeks. Most recently, 公众号助手 was updated on November 19, 2026 and EviMed on November 17, 2026.

Other comparisons